Coronavirus: Resilience during a year of the pandemic

Coronavirus: Resilience during a year of the ...

Up next

Living in Greenland

Described by Donald Trump as “a giant piece of ice,” the world’s largest island has found itself at the centre of global attention. The president’s demands to take over the self-governing Danish territory, potentially even by force, led to a diplomatic crisis and the president th ...  Show more

Daughters of thunder

In small towns and rural areas across the south of the United States traditional family churches have long been key guardians of black culture, memory and community spirit. Until very recently women called to preach in these communities faced opposition ranging from grudging acce ...  Show more

Recommended Episodes

A new phase in the Covid pandemic
The Real Story

After two-and-a-half years of Covid rampaging across the planet, causing millions of deaths and transforming billions of lives, everyone is keen to move on. But this week the head of the World Health Organization warned the public that the pandemic is “nowhere near over” and that ...  Show more

BONUS: The 1957 Pandemic That Wasn’t
Sidedoor

In 1918, a flu pandemic killed more than 50 million people worldwide. Forty years later, it nearly happened again. This week on Sidedoor we go back to a time when the viruses were winning, and we remember one man, Dr. Maurice Hilleman, whose vaccine virtuosity helped turn the ...

  Show more

The Evidence: When will the pandemic end?
Discovery

Everybody hopes that the new super-charged Omicron variant of coronavirus will be less severe, but even if it is, it’s spreading so fast and infecting so many people, health services around the world could still buckle under the strain.Two years into the pandemic, Claudia Hammond ...  Show more

430. Will a Covid-19 Vaccine Change the Future of Medical Research?
Freakonomics Radio

We explore the science, scalability, and (of course) economics surrounding the global vaccine race. Guests include the chief medical officer of the first U.S. firm to go to Phase 3 trials with a vaccine candidate; a former F.D.A. commissioner who’s been warning of a pandemic f ...

  Show more